| Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteers (NCT05202288) | ANRS, Emerging Infectious Diseases | 2027-01-01 |
| EBOla Post-Exposure Prophylaxis (NCT06841614) | ANRS, Emerging Infectious Diseases | 2026-09-01 |
| Intestinal Tissue-Resident Memory T Cells and HIV-1 Persistence During Antiretroviral Therapy (NCT07656077) | ANRS, Emerging Infectious Diseases | 2026-08-01 |
| Detection of Specific Metabolic Signatures by Nuclear Magnetic Resonance or Metabolomic NMR in Correlation With Markers of Inflammation or Immune Activation and the Risk of Developing Neurocognitive Disorders - Longitudinal Retrospective Study Nested in the ANRS12225 PEDIACAM III Cohort (NCT07770568) | ANRS, Emerging Infectious Diseases | 2026-08-01 |
| Assessment of Immune Memory - Humoral and Cellular - in mPOX-infected Patients : an Ancillary Study of the ANRS0258s MOSAIC Cohort (NCT07592429) | ANRS, Emerging Infectious Diseases | 2026-07-01 |
| An Experimental Medicine Multicenter Trial to Evaluate the Safety and Immunogenicity of Experimental Versus Authorized SARS-CoV-2 Vaccine Candidates as a Booster Dose in Healthy Participants Previously Vaccinated With Authorized mRNA SARS-CoV-2 Vaccines. (NCT07605520) | ANRS, Emerging Infectious Diseases | 2026-05-13 |
| Prospective Cohort of People Starting Treatment for Tuberculosis Disease in France (FrenchTB) (NCT06893757) | ANRS, Emerging Infectious Diseases | 2026-05-06 |
| Immunotherapy With Baricitinib and Sirolimus, Alone and in Combination, for the Control of HIV-1 Replication After Antiretroviral Treatment Interruption (NCT07081763) | ANRS, Emerging Infectious Diseases | 2026-05-01 |
| Frailty, Geriatric Syndromes and Care Pathways of Older Adults Living With HIV in West Africa (NCT07355413) | ANRS, Emerging Infectious Diseases | 2026-03-01 |
| "Pregnancy and Viral Infections: Impact on Pregnant Women and Their Children. French Prospective Cohort" (NCT07412977) | ANRS, Emerging Infectious Diseases | 2026-02-01 |
| "HBV unIversal vs Point-Of-Care-based Antiviral treatMent to Prevent Mother-to-child Transmission" (NCT07054359) | ANRS, Emerging Infectious Diseases | 2025-11-01 |
| Diagnostics and Surveillance of Acute Meningo-encephalitis Among Children in Cambodia With a Focus on Japanese Encephalitis Virus (NCT06674837) | ANRS, Emerging Infectious Diseases | 2025-10-15 |
| Access to Hepatitis C Treatment in Cameroon: Comparison of a Simplified Test and Treat Strategy to a Standard Strategy (NCT07098481) | ANRS, Emerging Infectious Diseases | 2025-09-01 |
| Study of the Prevalence of Transmitted HIV-1 Resistance, Viral Diversity, and Cluster Identification in Patients at the Time of HIV-1 Diagnosis (NCT07146529) | ANRS, Emerging Infectious Diseases | 2025-09-01 |
| HIV-1 Non-group M in Cameroon : Study of Genotypic and Phylogenetic Diversity (OBSOCAM) (NCT06913959) | ANRS, Emerging Infectious Diseases | 2025-06-30 |
| Dose Escalation Trial of CD40.Pan.CoV Vaccine, Adjuvanted or Not, as a Booster in Adult Healthy Volunteers (NCT07113106) | ANRS, Emerging Infectious Diseases | 2025-06-18 |
| Study Comparing Safety and Immunogenicity of Intranasal COVID-19 Vaccine and mRNA Booster in Healthy Adults (NCT06821126) | ANRS, Emerging Infectious Diseases | 2025-05-09 |
| A Study to Determine the Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing bictégravir, Emtricitabine and ténofovir alafénamide (NCT05222945) | ANRS, Emerging Infectious Diseases | 2025-04-01 |
| Prevalence of Drug-resistant Hiv-1 Strains in Patients Experiencing Virologic Failure. (MULTIVIR2025) (NCT06842706) | ANRS, Emerging Infectious Diseases | 2025-04-01 |
| Identification of Molecular Signatures of High-risk Oncogenic HPV and Study of Their Associations With the Presence of High-grade Lesions and/or Anal Cancer 10 Years After Inclusion in the ANRS IPERGAY Trial (NCT06522256) | ANRS, Emerging Infectious Diseases | 2025-03-20 |
| Study Evaluating the Safety, in Terms of HBV Virological Control At 96 Weeks, of 2 Antiviral Treatment Relief Strategies, in Patients Co-infected with the HIV-1 and HBV Viruses (NCT06338826) | ANRS, Emerging Infectious Diseases | 2025-02-01 |
| DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 Infection (NCT06203132) | ANRS, Emerging Infectious Diseases | 2025-01-27 |
| Immunity to Yellow Fever in HIV-infected Patients 10 Years After a Primary Anti-yellow Fever Vaccination (NCT05450770) | ANRS, Emerging Infectious Diseases | 2024-11-01 |
| Efficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in Thailand and France. (NCT05813964) | ANRS, Emerging Infectious Diseases | 2024-06-05 |
| Assisted Notification of Partners of Men Having Sex With Men Discovering Their Seropositivity (NCT06419491) | ANRS, Emerging Infectious Diseases | 2024-06-01 |
| Pilot Implementation of HIV Self-testing Delivery in Private Pharmacies Combined to a Respondent Driven Sampling Method to Improve HIV Testing for MSM and TGW in Phnom Penh - ANRS 0100s (NCT05745168) | ANRS, Emerging Infectious Diseases | 2024-06-01 |
| Safety and Immunogenicity of a Sub-unit Protein CD40.RBDv Bivalent COVID-19 Vaccine, Adjuvanted or Not, as a Booster in Volunteers. (NCT06255626) | ANRS, Emerging Infectious Diseases | 2024-05-27 |
| Negative Serology by Immunoenzymatic Test (EIA) in HIV-infected Children Treated Early With Antiretroviral in the ANRS-Pediacam Study: Pathophysiological Mechanisms (NCT06302933) | ANRS, Emerging Infectious Diseases | 2024-05-02 |
| Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control (NCT05300035) | ANRS, Emerging Infectious Diseases | 2024-04-11 |
| Impact of Long-acting Injectable Cabotegravir for HIV PrEP in MSM in France. (NCT06273943) | ANRS, Emerging Infectious Diseases | 2024-04-01 |
| Post-COVID-19 Condition: Observational Study in Vietnam (NCT06022211) | ANRS, Emerging Infectious Diseases | 2023-12-01 |
| Implementation and Effectiveness of Physical Activity to Prevent Disability in HIV-infected Adults Older Than 50 From Côte d'Ivoire (NCT06139497) | ANRS, Emerging Infectious Diseases | 2023-10-31 |
| DRug Use & Infections in ViEtnam: TuBerculosis Control (NCT05655702) | ANRS, Emerging Infectious Diseases | 2023-10-02 |
| Community Intervention to Eliminate HCV Among People Who Use Drugs. (NCT05794646) | ANRS, Emerging Infectious Diseases | 2023-10-02 |
| HPV Infection, Sexually Transmitted Infections and Anal Dysplasia in the Transgender Population (NCT05981807) | ANRS, Emerging Infectious Diseases | 2023-10-01 |
| Seroprevalence of Monkeypox Infection Among People Living With HIV and PrEP Users (NCT05922735) | ANRS, Emerging Infectious Diseases | 2023-09-01 |
| Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokombéré, Cameroon in Pregnant Women (NCT05403047) | ANRS, Emerging Infectious Diseases | 2023-08-22 |
| Study of DAA Treatment for Children and Adolescents With Active HCV Infection in Cambodia (NCT05992077) | ANRS, Emerging Infectious Diseases | 2023-08-07 |
| OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy Trial (NCT05587894) | ANRS, Emerging Infectious Diseases | 2023-04-27 |
| Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis (NCT05590455) | ANRS, Emerging Infectious Diseases | 2023-04-11 |
| Assessment of HIV Remission Upon cART Interruption in Early Treated Individuals Carrying the MHC B35/53Bw4TTC2 Genotype (NCT05482854) | ANRS, Emerging Infectious Diseases | 2023-03-20 |
| Assessment of the Efficacy and Safety of Tecovirimat in Patients With Monkeypox Virus Disease (NCT05597735) | ANRS, Emerging Infectious Diseases | 2023-03-03 |
| Evaluation of the Safety and the Tolerability of a Combination of Two HIV Inducers in Patients With Undetectable Viral Load (NCT05230368) | ANRS, Emerging Infectious Diseases | 2022-12-14 |
| Aging With HIV and Neurocognitive Decline, a Follow-up Study (NCT05385588) | ANRS, Emerging Infectious Diseases | 2022-11-14 |
| Variants of SARS-CoV-2 Causing COVID-19 in Africa (NCT05311891) | ANRS, Emerging Infectious Diseases | 2022-09-01 |
| A Prophylactic HIV Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Clade C DREP Alone and in Combination With a Clade C ENV Protein in Healthy HIV-uninfected Adults (NCT04844775) | ANRS, Emerging Infectious Diseases | 2022-08-05 |
| A HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02) (NCT04120415) | ANRS, Emerging Infectious Diseases | 2022-06-21 |
| Expectation, Motivation and Experience of HIV-patients Regarding Participation to an HIV Cure-related Clinical Trial (NCT05280392) | ANRS, Emerging Infectious Diseases | 2022-06-21 |
| Evaluation of the Immunogenicity and Safety of Ad26.COV2.S's COVID-19 Vaccine (NCT05409261) | ANRS, Emerging Infectious Diseases | 2022-06-02 |
| Large Scale Transition to a Dolutegravir-based First-line ART in the South: Virological Response and Impact on HIV Drug Resistance in a Real Life Context (DoReaL Study) (NCT05312918) | ANRS, Emerging Infectious Diseases | 2022-05-01 |
| Evaluation of the Immunogenicity and Safety BBIBP-CorV Vaccine for COVID-19 in Adults in Guinea (NCT05409300) | ANRS, Emerging Infectious Diseases | 2022-04-25 |
| Community Versus Facility-based Services to Improve the Screening of Active HCV Infection in Cambodia (NCT03992313) | ANRS, Emerging Infectious Diseases | 2022-04-21 |
| Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Suppression (NCT04738812) | ANRS, Emerging Infectious Diseases | 2022-04-21 |
| Drug Use & Infections in ViEtnam: Mental Health Intervention for INjecting Drug Users (NCT05886504) | ANRS, Emerging Infectious Diseases | 2022-03-28 |
| Evaluation of Measurement of Maternal Viral Load at Delivery to Optimise Post-natal Prophylaxis of HIV-exposed Newborns (NCT05017558) | ANRS, Emerging Infectious Diseases | 2022-03-01 |
| Prevention of Mental Health Problems Among Persons Without Personal Housing in the Context of the COVID-19 Epidemic (NCT05033210) | ANRS, Emerging Infectious Diseases | 2022-03-01 |
| Health and Migration Trajectories of Housekeepers in Bamako (NCT05472051) | ANRS, Emerging Infectious Diseases | 2022-02-28 |
| ANRS HB07 IP-Cure-B Proof of Concept (PoC) Clinical Trial. Educating the Liver Immune Environment Through TLR8 Stimulation Followed by NUC Discontinuation (NCT05045261) | ANRS, Emerging Infectious Diseases | 2022-02-01 |
| Pre-exposure Prophylaxis of SARS-CoV-2 Infection (COVID-19) by Monoclonal Antibodies With Early Access Authorization in Immunocompromised Patients. A Prospective Cohort. (NCT05216588) | ANRS, Emerging Infectious Diseases | 2022-01-26 |
| Prophylaxis Vaccine Antibodies Ebola (NCT04822376) | ANRS, Emerging Infectious Diseases | 2021-10-17 |
| Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') OR or Authorisation for Early Access (AAP). A Prospectvie Cohort. (NCT04885452) | ANRS, Emerging Infectious Diseases | 2021-09-21 |
| Transmission of Covid-19 During Clubbing Events in Closed Places (NCT05311865) | ANRS, Emerging Infectious Diseases | 2021-09-04 |
| Epidemiological Investigation of COVID-19 in Laos Using a One-Health Approach in Human and Animals (NCT04716543) | ANRS, Emerging Infectious Diseases | 2021-08-01 |
| Partner Notification of Sexually Transmitted Infections (STIs) in Testing Centers (NCT04921618) | ANRS, Emerging Infectious Diseases | 2021-07-12 |
| Prevalence and Longitudinal Follow-up of Anal Lesions, HPV Infection and Associated Sexually Transmitted Infections Among Men Who Have Sex With Men in Togo. (NCT04910438) | ANRS, Emerging Infectious Diseases | 2021-06-24 |
| Dual Therapy in HIV Patients in 4 Days a Week Versus 7 Days a Week (NCT04867083) | ANRS, Emerging Infectious Diseases | 2021-06-21 |
| Protective Measures Against SARS-CoV-2 Contamination of Young Healthy Volunteers During a Concert of Actual Music (NCT04868942) | ANRS, Emerging Infectious Diseases | 2021-05-01 |
| ANRS 12406 EvvA Study (NCT04593979) | ANRS, Emerging Infectious Diseases | 2021-04-15 |
| HIV Acquisition and Life Course of Born-abroad Men Who Have Sex With Men Living in Ile-de-France: the GANYMEDE Study (NCT04684758) | ANRS, Emerging Infectious Diseases | 2021-04-14 |
| Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection (NCT04920838) | ANRS, Emerging Infectious Diseases | 2021-04-12 |
| Dose Escalation Trial of CD40.HIVRI.Env Vaccine Combined or Not With a DNA-HIV-PT123 HIV-1 Vaccine in Healthy Volunteers (NCT04842682) | ANRS, Emerging Infectious Diseases | 2021-03-29 |
| Severity of the New UK SARS-Cov2 Variant in COVID-19 Infection (NCT04863547) | ANRS, Emerging Infectious Diseases | 2021-03-11 |
| BNT162b2 Vaccination With 2 Doses in COVID-19 Negative Volunteers and With a Single Dose in COVID-19 Positive Volunteers (NCT04824638) | ANRS, Emerging Infectious Diseases | 2021-03-08 |
| Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis (NCT04145258) | ANRS, Emerging Infectious Diseases | 2021-02-07 |
| Combined Prevention of Sexually Transmitted Infections (STIs) in Men Who Have Sex With Men and Using Oral Tenofovir Disoproxil Fumarate/ Emtricitabine (TDF/FTC) for HIV Pre-Exposure Prophylaxis (PrEP) (NCT04597424) | ANRS, Emerging Infectious Diseases | 2021-01-19 |
| ANRS 12392 Sanu Gundo (NCT04482010) | ANRS, Emerging Infectious Diseases | 2020-11-29 |
| National Survey About Trajectory and Life Conditions of HIV Trans People in France (NCT04849767) | ANRS, Emerging Infectious Diseases | 2020-10-01 |
| ANRS 12372 MODERATO Study (NCT04022967) | ANRS, Emerging Infectious Diseases | 2020-09-21 |
| A Community-based Intervention Among Active Drug Users in Montpellier (NCT04008927) | ANRS, Emerging Infectious Diseases | 2020-09-18 |
| Cross Sectional Survey on the Burden, Impacts and Causes of Hepatitis C Virus (HCV) Outbreak in South West Region in Burkina Faso (NCT04136405) | ANRS, Emerging Infectious Diseases | 2020-07-14 |
| National Cohort of Patients Co-infected With Hepatitis B and Delta Viruses (NCT04166266) | ANRS, Emerging Infectious Diseases | 2020-02-19 |
| Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing Dolutegravir and Associated Nucleoside / Nucleotide Reverse Transcriptase Inhibitors Backbone (NCT04133012) | ANRS, Emerging Infectious Diseases | 2020-02-10 |
| Lowering InterLeukin-1 Receptor Antagonist Concentrations After TB Treatment Onset (NCT04015713) | ANRS, Emerging Infectious Diseases | 2020-01-21 |
| Prevention of Mother-to-child Transmission of HIV-1 Using a Responsive Intervention (NCT03870438) | ANRS, Emerging Infectious Diseases | 2019-12-14 |
| Preventing Childhood HIV: Rescue Intervention. ANRS 12388 PREVENIR-PEV (NCT03869944) | ANRS, Emerging Infectious Diseases | 2019-12-04 |
| Reducing Antiretroviral Treatments (NCT04051970) | ANRS, Emerging Infectious Diseases | 2019-11-27 |
| HIV and HCV Infections in 2 Communes From the Battambang Province, Cambodia: Prevalence Rates, Viral Strains, and Unsafe Injection Practices (12352 ANRS ROK INVEST) (NCT04044586) | ANRS, Emerging Infectious Diseases | 2019-09-01 |
| ANRS12373 GUNDO SO - Evaluation of an Empowerment Program for WLHIV in Mali (NCT03795415) | ANRS, Emerging Infectious Diseases | 2019-05-27 |
| Frailty in People Living With HIV Aged 70 Years or More (NCT03958786) | ANRS, Emerging Infectious Diseases | 2019-05-15 |
| Evaluation of Triage Options After HPV Testing for Cervical Cancer Screening Among HIV-infected Women (NCT03789513) | ANRS, Emerging Infectious Diseases | 2019-03-01 |
| An HIV Vaccine Trial in Individuals Who Started ART During Primary or Chronic Infection (NCT02972450) | ANRS, Emerging Infectious Diseases | 2019-02-20 |
| DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C) (NCT03537196) | ANRS, Emerging Infectious Diseases | 2018-11-13 |
| Evaluation of Third-line cART Regimen in Cambodia (3DICAM) (NCT03602690) | ANRS, Emerging Infectious Diseases | 2018-10-04 |
| Role of the IL33/Amphiregulin Pathway as a Potential Therapeutic Target in HIV Infection (NCT03622177) | ANRS, Emerging Infectious Diseases | 2018-09-01 |
| Methylphenidate for Cocaine Dependence (NCT03090269) | ANRS, Emerging Infectious Diseases | 2018-06-01 |
| "Real Life" Evaluation of Efficacy and Safety of Direct Antiviral Agents (DAAs) for the Treatment of Hepatitis C Virus in Egypt (NCT03510637) | ANRS, Emerging Infectious Diseases | 2018-01-22 |
| ANRS CO24 OncoVIHAC (Onco VIH Anti Checkpoint) (NCT03354936) | ANRS, Emerging Infectious Diseases | 2018-01-17 |
| Access to PrEP for MSM: Acceptability and Feasibility in Community-based Clinics in West Africa (CohMSM-PrEP) (NCT03459157) | ANRS, Emerging Infectious Diseases | 2017-11-20 |
| Cross Sectional Survey on the Burden and Impacts of Chronic Hepatitis B in the Rural Area of Niakhar, Senegal (NCT03215732) | ANRS, Emerging Infectious Diseases | 2017-10-19 |
| Tenofovir As Prevention Of Hepatitis b Mother-to-child Transmission (NCT02937779) | ANRS, Emerging Infectious Diseases | 2017-10-04 |